This invention relates to modified double-stranded oligoribonucleic acid (dsRNA) having improved stability in cells and biological fluids, and methods of making and identifying dsRNA having improved stability, and of using the dsRNA to inhibit the expression or function of a target gene.


< Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases

< Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics

> Immunostimulatory oligonucleotide multimers

> Immunomodulatory oligonucleotides

~ 00258